3[1]Vitalic-Bombardieri S,Jonsson R,et al.Classification criteria for Sj(o)gren's syndrome:a revised version of the European criteria proposed by the American-European Consensus Group.Ann Rheum Dis,2002,61(6):554-558.
4[2]Bohan A,Peter JB.Polymyositis and dermatomyositis(first of two parts).N Engl J Med,1975,292:344.
5[4]Maddison PJ.Overlap syndromes and mixed connective tissue disease.Curr Opin Rheumatol,1991,3(6):995.
6[5]Morita T,Shimada A,Yashiro S,et al.Myofiber expression of class I major his tocompatibility complex accompanied by CD+8 T-cell-associated myofiber injury in a case of canine polymyositis.Vet Path ol,2002,39(4):512-515.
7[6]Robert L.HLA in health and disease.A cademic Press,2000:353.
8[7]Takada T,Suzuki E,Nakano M,et al.Clinical features of polymyositis /dermatomyositis with steroid resistinal intastitial lung disease.Intern Med,1998,37(8):669-673.
9[8]Danko K,Pouyi A,Constantin T.Long-term survival of patients with idiopathic inflammatory myopathies.According to clinical features:a longitudinal study of 162 cases.Medicine(Baltimoro),2004,83(1):35-42.
10Davidson BKS,Kelly CA,Griffiths ID.Primary Sj(o)gren's syndrome in the North East of England:a long-term follow-up study.Rheumatology,1999,38:245-253.
